🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Status
Not Yet Recruiting
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2024-04-30
Trial ID
NCT06370754
This is a Multicenter, Non-randomized, Open Label, Multiple Dose, Multiple ...
Status
Completed
Location
Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2020-09-28
Trial ID
NCT04381910
Treatments Being Tested
The current study is an investigator-initiated, single-arm phase 2 study th...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-04-15
Trial ID
NCT06827717
Treatments Being Tested
To determine the safety and tolerability of irinotecan liposome in combinat...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2021-04-08
Trial ID
NCT04796948
Treatments Being Tested
Phase II clinical study of irinotecan liposome (II)-based combination regim...
Status
Recruiting
Location
Chinese PLA General Hospital, Beijing,
Start Date
2024-09-01
Trial ID
NCT07044921
Treatments Being Tested
To evaluate the efficacy and safety of irinotecan hydrochloride liposome in...
Status
Unknown
Location
Peking Union Medicalcollege Hospital
Start Date
2024-06-30
Trial ID
NCT06430827
Treatments Being Tested
The purpose of this study is to look at the efficacy and safety of Irinotec...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04083235
Treatments Being Tested
Guidelines recommend FOLFIRI in combination with bevacizumab or cetuximab a...
Status
Recruiting
Location
The second affiliated hospital, Zhejiang University School of Medicine
Start Date
2024-11-12
Trial ID
NCT06540326
Treatments Being Tested
This Phase II, single-arm, single-center study evaluates the conversion to ...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2025-05-25
Trial ID
NCT06993025
Treatments Being Tested
The purpose of this study is to characterize the safety of ONIVYDE when use...
Status
Completed
Location
Konyang University Hospital
Start Date
2018-03-08
Trial ID
NCT03446872
Treatments Being Tested